Cargando…
MicroRNA-181a–2–3p shuttled by mesenchymal stem cell-secreted extracellular vesicles inhibits oxidative stress in Parkinson’s disease by inhibiting EGR1 and NOX4
The current study investigated the physiological mechanisms by which extracellular vesicle (EV)-encapsulated miR-181a–2–3p derived from mesenchymal stem cells (MSCs) might mediate oxidative stress (OS) in Parkinson’s disease (PD). First, 6-hydroxydopamine (6-OHDA)-induced PD cell and mouse models we...
Autores principales: | Ma, Jianjun, Shi, Xiaoxue, Li, Mingjian, Chen, Siyuan, Gu, Qi, Zheng, Jinhua, Li, Dongsheng, Wu, Shaopu, Yang, Hongqi, Li, Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786891/ https://www.ncbi.nlm.nih.gov/pubmed/35075150 http://dx.doi.org/10.1038/s41420-022-00823-x |
Ejemplares similares
-
miR-494-3p Promotes Erastin-Induced Ferroptosis by Targeting REST to Activate the Interplay between SP1 and ACSL4 in Parkinson's Disease
por: Ma, Jianjun, et al.
Publicado: (2022) -
Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in Parkinson’s disease patients
por: Shi, Xiaoxue, et al.
Publicado: (2022) -
Plasma arylsulfatase A levels are associated with cognitive function in Parkinson’s disease
por: Li, Mingjian, et al.
Publicado: (2022) -
Increased Plasma Heme Oxygenase-1 Levels in Patients With Early-Stage Parkinson’s Disease
por: Sun, Wenhua, et al.
Publicado: (2021) -
Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson’s Disease
por: Hu, Shiyu, et al.
Publicado: (2021)